Inside Precision Medicine February 27, 2025
Chris Anderson

Researchers, led by a team from Baylor College of Medicine, have developed a new artificial intelligence (AI) approach that has accelerated the identification of genes contributing to neurodevelopmental disorders (NDDs) such as autism spectrum disorder, epilepsy, and developmental delay. Study details, published in the American Journal of Human Genetics, show the new models can play an important role in fully characterizing the NDD genetic landscape, information that can improve diagnosis and the development of new targeted therapies.

“Although researchers have made major strides identifying different genes associated with neurodevelopmental disorders, many patients with these conditions still do not receive a genetic diagnosis, indicating that there are many more genes waiting to be discovered,” said first author Ryan S. Dhindsa, MD,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
Using AI to help doctors connect with patients
Versatile AI system can detect subtle changes in series of medical images
19 top tech platforms for value-based care, population health
The Age Of Giant Centralized AI May Be At An End
A health CEO’s crucial AI meeting

Share This Article